Exscientia Investor Presentation Deck
June 2022, 37 slides
  1. Exscientia
  2. Related Decks
  3. Investor Presentation Decks
better drugs faster patient first drug creation | Exscientia
forward looking statements | Exscientia
better drugs faster ail | Exscientia
our first achievements in first | Exscientia
delivering results across partnerships | Exscientia
taking projects from ideas to the clinic | Exscientia
deal highlights industry shift in drug discovery | Exscientia
we are a | Exscientia
transforming with technology | Exscientia
outstanding efficiency in drug discovery | Exscientia
foundations for transforming an industry | Exscientia
pipeline balanced across business models | Exscientia
rapidly scaling pipeline doing more to learn more projects in progress | Exscientia
how patient first can produce better drugs faster | Exscientia
patient first is a learning process | Exscientia
extensive proprietary data generation capabilities | Exscientia
well positioned to deliver data at highlighted patient | Exscientia
platforms | Exscientia
and validating targets with centaur biologist | Exscientia
our differentiated process | Exscientia
case study year old patient with diffuse large cell lymphoma | Exscientia
exalt study results | Exscientia
target discovery in primary patient tissues ere tee eer | Exscientia
defining patient selection during drug design hates | Exscientia
precision objectives for precision design | Exscientia
data and model agnostic | Exscientia
| Exscientia
active learning leads to creative breakthroughs | Exscientia
technology in action case study exs | Exscientia
inhibition provides broad oncology opportunity | Exscientia
precision design to effectiveness | Exscientia
design flaws can impact clinical outcomes | Exscientia
our exs candidate resolves critical design issues | Exscientia
i highly effective in classical models | Exscientia
i sparing immune cells in comparison to i | Exscientia
i defining patient selection during drug design breed | Exscientia
| Exscientia
See More
Exscientia
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Cancer
Ovarian
Ovarian cancer
Drug discovery
Recent decks by Exscientia
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
See all presentations by Exscientia (14 decks)
Related decks
Alkermes
Investor Presentation
October 2023
Genelux
Investor Presentation
July 2023
Alkermes
Investor Day
March 2021
TCR2 Therapeutics
Results
September 2022
Genelux
Investor Presentation
October 2023
Immatics
Investor Presentation
November 2023
Genelux
Investor Presentation
February 2024
AstraZeneca
Investor Event
June 2023
Recent decks by Exscientia
See all presentations (14 decks)
Investor Presentation
March 2024
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Alkermes
Investor Presentation
October 2023
Genelux
Investor Presentation
July 2023
Alkermes
Investor Day
March 2021
TCR2 Therapeutics
Results
September 2022
Genelux
Investor Presentation
October 2023
Immatics
Investor Presentation
November 2023
Genelux
Investor Presentation
February 2024
AstraZeneca
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights